6Brophy S, Yderstraede K, Mauricio D, et al. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults [ J ]. Diabets Care,2008,31:439-441.
7BaigentC, KeechA, KearneyPM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins[J]. Lancet, 2005, 366(9493):1267-1278.
8KearneyPM, BlackwellL, CollinsR, et al. Efficacy of cholesterol-lowering therapy in 18, 686 people with diabetes in 14 randomised trials of statins: a meta-analysis[J]. Lancet, 2008, 371(9607):117-125.
9HoogeveenRC, GaubatzJW, SunW, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study[J]. Arterioscler Thromb Vasc Biol, 2014, 34(5):1069-1077.
10SchmidtSA, Heide-J?rgensenU, ManthripragadaAD, et al. Prevalence and characteristics of patients with low levels of low-density lipoprotein cholesterol in northern Denmark: a descriptive study[J]. Clin Epidemiol, 2015, 7:201-212.
